GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » Short-Term Capital Lease Obligation

GNMLF (Genomma Lab InternacionalB de CV) Short-Term Capital Lease Obligation : $0.0 Mil (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Genomma Lab InternacionalB de CV Short-Term Capital Lease Obligation?

Genomma Lab InternacionalB de CV's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.0 Mil.

Genomma Lab InternacionalB de CV's annual Short-Term Capital Lease Obligation declined from Dec. 2021 ($1.6 Mil) to Dec. 2022 ($1.3 Mil) and declined from Dec. 2022 ($1.3 Mil) to Dec. 2023 ($1.1 Mil).

Genomma Lab InternacionalB de CV Short-Term Capital Lease Obligation Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Short-Term Capital Lease Obligation Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 1.85 1.60 1.30 1.14

Genomma Lab InternacionalB de CV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.14 - - -

Genomma Lab InternacionalB de CV Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Genomma Lab InternacionalB de CV Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
MEX:PINFRA MEX:RA MEX:GSANBORB-1 MEX:SORIANAB MEX:PASAB MEX:CMOCTEZ MEX:CULTIBAB MEX:JAVER MEX:GPROFUT MEX:ACCELSAB ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
LABB:Mexico GEKA:Germany
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Website
https://www.genommalab.com
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.